(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
    • Natural Health Products
    • Drugs
    • Medical Devices
    • Consumer Products
    • Technology
    • FDA Consulting
    • Health Canada Consultants
    • Regulatory Affairs
    • Pharmacovigilance Services
  • Innovation
  • Articles
  • Contact
Select Page
A Risk-Based Approach to Site License Applications

A Risk-Based Approach to Site License Applications

by Carley Lovnicki | Nov 13, 2020 | Canadian Regulatory, Natural Health Products

In attempt to eliminate the recent issue of site license renewal backlogs, the Natural and Non-Prescription Health Products Directorate (NNHPD) is implementing a new risk based approach to the site license application. With an ambitious goal of removing all backlog by...
COVID-19 and Vitamin D: Correlation or Coincidence?

COVID-19 and Vitamin D: Correlation or Coincidence?

by Carley Lovnicki | Nov 3, 2020 | Canadian Regulatory, Research/Science/Technology

The past several months have unquestionably been inundated with what sometimes feels like constant streams of new information and theories surrounding the global virus, COVID-19. Some of the most thought-provoking of which concern a potential correlation between...
New Canadian Cosmetic Ingredient Hotlist Updates

New Canadian Cosmetic Ingredient Hotlist Updates

by Carley Lovnicki | Oct 22, 2020 | Canadian Regulatory, Cosmetics

Earlier this month, Health Canada released a new list of proposed updates to the Cosmetic Ingredient Hotlist, which included new additions, as well as revisions, to both the restricted and prohibited cosmetic ingredient lists. The proposed new additions to the...
Health Canada: Changing Up the Sample Game

Health Canada: Changing Up the Sample Game

by Emily C | Jun 4, 2020 | Canadian Regulatory, Natural Health Products, OTC Drugs

Health Canada has recently released updates applicable to Natural Health Products and Non-Prescription Drug Regulations. Beginning July 1st, associated industries will be able to distribute certain types of these products as free samples. Distribution of NHP and...

Recent Posts

  • FDA OTC MONOGRAPH DRUG USER FEE RATES FOR FISCAL YEAR 2021
  • Phase I of the Self-Care Framework
  • Changes to INCI Names for Hydrocarbons
  • Health Canada Risk Evaluation of N-nitrosamine Impurities: First Step Deadline Fast Approaching
  • Interim Order No. 2 Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19 (IO No. 2)

Recent Comments

    Archives

    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • Canadian Quality Assurance
    • Canadian Regulatory
    • Cosmetics
    • European Regulatory
    • Events/Company Updates
    • Importation of NHPs
    • Innovation
    • Innovation
    • Medical Devices
    • Natural Health Products
    • OTC Drugs
    • Our View
    • Research/Science/Technology
    • U.S. Regulatory
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2021 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY